Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Opioid Packaging Standards Could Emerge From Dosage Guidelines in Labeling

Executive Summary

US FDA wants to work with practitioners to develop suggested prescribing standards, which could then be used to create packaging requirements.


Related Content

OTC Switch For Naloxone Finding Interest Among Sponsors
OTC Switch For Naloxone Finding Interest Among Sponsors
Opioid Prescribing Guidelines Will Be More Template Than Commandment
Opioid Blister-Pack Mandate Tops Gottlieb's Agenda With New Authority
Opioid Prescribing Guidelines Put US FDA In Unfamiliar Territory
Opioid Treatments Could Get Survival Claim As US FDA Develops Protocol
Opioid Packaging Changes Might Deter Abuse – And Generic Competition
FDA's Opioid Programs: After Training, What's The Next Step?
US FDA May Change Opioid Labeling To Limit Dispensing By Indication
Generic Abuse Deterrent Opioids: FDA Offers Tier-Based Testing Approach


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts